Clear Scientific, Inc.
Clear Scientific, Inc. is a biopharmaceutical company dedicated to pioneering novel therapies for life-threatening and debilitating conditions caused by harmful substances in the body. Their mission is to develop life-saving medicines that effectively remove the cause of ailments to alleviate their effects.
Clear Scientific, Inc.
737 Concord Avenue, Cambridge, MA 02138
What We Do
CS-1103
A sequestrant drug designed to treat overdoses caused by methamphetamine, fentanyl, and their co-use, as well as metabolic and neurodegenerative condition-induced CNS dysfunction.
Drugs
Application Area
Regenerative Medicine
Key People
Shekar Shetty
Chief Executive Officer
Xinhua Li, PhD
EVP, Drug Development
Peter Howe
Chief Financial Officer
Mitch Zakin, PhD
EVP, Innovation
Winston Henderson, JD
General Counsel
News & Updates
The Clear Scientific team joined the Shatterproof Walk to End Addiction Stigma at Carson Beach in Boston, MA.
Peter Howe and Charlotte Leggett from Clear Scientific attended the 2024 American College of Emergency Physicians Scientific Assembly in Las Vegas, NV.
Clear Scientific announced a $3M award from the National Institute on Drug Abuse to support the development of an antidote for fentanyl and xylazine combinations.
Clear Scientific reported positive topline data from a Phase 1 clinical trial for CS-1103.